CEO SUMMARY: Genetic tests that lack two essentials are troublesome for the nation’s health insurers. Those essentials are clinical validity and clinical utility. During a recent webinar, two executives from major health insurers stressed the need for genetic testing labs to provide acceptable evidence that their genetic test is accurate and that it produces information
Health Insurers Want More Data On Clinical Utility of Molecular, Genetic Tests
By Joseph Burns, from the Volume XXIV, No. 4 – March 13, 2017 issue